Application Note

Milliflex® Rapid System To Test Cell-Based Immunotherapeutics For Microbial Contaminants

Milliflex® Rapid System Feature

Immunotherapy, an established cancer treatment, often uses activated T cells. While swift release is vital for optimal efficacy, ensuring microbiological safety is equally crucial. The Milliflex® Rapid System, an automated ATP-based system, swiftly detects images and quantifies viable microbial contaminants in filterable samples during manufacturing. By prioritizing microbiological safety, it streamlines the production and release process, ensuring patient safety while expediting treatment availability.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online